Summary:
This is a multi-center, multi-country, double-blind, randomized, parallel-group, placebo-controlled, Phase 3 intervention study in post-menopausal women with vasomotor (hot flash) symptoms.
Qualified Participants Must:
• Postmenopausal females aged 40 to 65 years, inclusive, at signing of informed consent
Qualified Participants May Receive:
Health Checks, Assessments & Physical Examination in relation to study no cost to you. Access to study drug while in study and compensation for qualifying participants.